-
IONS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Ionis Pharmaceuticals (IONS)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 334.61 mm | 334.61 mm | 334.61 mm | 334.61 mm | 334.61 mm | 334.61 mm |
Cash burn (monthly) | (no burn) | 1.45 mm | 49.55 mm | 30.87 mm | 38.33 mm | 29.33 mm |
Cash used (since last report) | n/a | 4.06 mm | 138.35 mm | 86.20 mm | 107.02 mm | 81.88 mm |
Cash remaining | n/a | 330.54 mm | 196.26 mm | 248.41 mm | 227.59 mm | 252.72 mm |
Runway (months of cash) | n/a | 227.2 | 4.0 | 8.0 | 5.9 | 8.6 |
13F holders | Current |
---|---|
Total holders | 356 |
Opened positions | 87 |
Closed positions | 43 |
Increased positions | 105 |
Reduced positions | 113 |
13F shares | Current |
---|---|
Total value | 5.90 tn |
Total shares | 158.60 mm |
Total puts | 510.30 k |
Total calls | 2.25 mm |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
FMR | 21.89 mm | $1.04 tn |
Vanguard | 13.85 mm | $659.89 bn |
T. Rowe Price Investment Management | 12.64 mm | $602.41 mm |
BLK BlackRock | 10.32 mm | $491.90 bn |
BBBOF BB Biotech | 9.64 mm | $0.00 |
BLVGF Bellevue | 8.26 mm | $393.69 bn |
Wellington Management | 6.57 mm | $313.07 bn |
BIIB Biogen | 5.75 mm | $347.39 mm |
STT State Street | 4.19 mm | $199.72 bn |
T. Rowe Price | 3.93 mm | $187.51 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Nov 24 | Brett P Monia | Common Stock | Sell | Dispose S | No | Yes | 38.0534 | 6,630 | 252.29 k | 167,393 |
12 Nov 24 | Joseph Loscalzo | Common Stock | Sell | Dispose S | No | Yes | 37.861 | 13,508 | 511.43 k | 32,251 |
12 Nov 24 | Eric Swayze | Common Stock | Sell | Dispose S | No | Yes | 37.921 | 1,194 | 45.28 k | 33,713 |
16 Oct 24 | Eric Swayze | Common Stock | Sell | Dispose S | Yes | No | 38.313 | 53 | 2.03 k | 157 |
15 Oct 24 | Eric Swayze | Common Stock | Option exercise | Acquire M | Yes | No | 0 | 125 | 0.00 | 210 |
15 Oct 24 | Eric Swayze | RSU Common Stock | Option exercise | Dispose M | Yes | No | 0 | 125 | 0.00 | 426 |
15 Oct 24 | Shannon L. Devers | RSU Common Stock | Grant | Acquire A | No | No | 0 | 11,280 | 0.00 | 42,521 |